Quality improvement in neurology: Dementia management quality measurement set update

Amy E Sanders1, James Nininger1, John Absher1

  • 1From the Department of Neurology (A.E.S.), SUNY Upstate Medical University, Syracuse; Department of Psychiatry (J.N.), Weill/Cornell Medical College, New York, NY; Absher Neurology, PA (J.A.); Alliance for Neuro Research, LLC (J.A.); University of South Carolina School of Medicine (J.A.), Greenville; Via College of Osteopathic Medicine (J.A.), Spartanburg, SC; American Academy of Neurology (A.B.), Minneapolis, MN; American Psychiatric Association (S.S.), Arlington, VA; Sheppard Pratt Health System (R.R.), Towson; Department of Psychiatry (R.R.), University of Maryland School of Medicine; and Department of Psychiatry (R.R.), John Hopkins University School of Medicine, Baltimore, MD.

Neurology
|May 3, 2017
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos

Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
614
Documentation in Long-Term and Home Healthcare Setting01:29

Documentation in Long-Term and Home Healthcare Setting

Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
1.6K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K